NON-GMP RESEARCH SERVICE

Baculovirus Insect Cell Protein Expression Service

BioCrestSci provides non-GMP baculovirus and insect cell protein expression for research targets that may benefit from eukaryotic folding and insect-cell processing. The workflow covers construct planning, Sf9 transfection and expression verification, small-scale production, basic purification and defined quality-control reporting.

A DECISION-READY WORKFLOW

Why Choose BioCrestSci

01

Baculovirus and host cell planning

Construct design, recombinant baculovirus preparation, Sf9 compatibility, infection strategy and target localization are considered before production.

02

Stage based expression evidence

Transfection, expression verification and small-scale production are separated into reviewable stages so infection and harvest decisions reflect observed performance.

03

Basic purification included

The $3,600 package includes basic protein purification and basic QC. Polishing, virus-related characterization, endotoxin control and bioactivity work are optional.

FROM CONSTRUCT TO CHARACTERIZATION

Six-Stage Baculovirus Insect Cell Protein Expression Workflow

Baculovirus Insect Cell protein expression six-stage workflow
Milestone-based planning keeps construct, expression, purification and characterization decisions aligned with the target protein.

SCOPE, DELIVERABLES AND PRICING

Stage 01–06 Technical Details

The standard package covers Stages 02–05. Stage 01 gene synthesis and Stage 06 options are separate. Final scope is confirmed after technical assessment.

Stage 01

Gene Synthesis and Vector Construction

Description

Prepare a baculovirus-compatible expression construct with an agreed coding region, processing signal and affinity tag.

Key Considerations

  • Sequence correctness
  • vector compatibility
  • domain boundaries
  • signal peptide
  • tag arrangement
  • reading frame
  • intended protein form.

Deliverables

Expression-ready construct and sequence or vector documentation.

Price

$1.55/aa, charged separately

Stage 02

Sf9 Transfection and Expression Verification

Description

Generate the recombinant baculovirus workflow, transfect Sf9 cells and assess target expression under defined verification conditions.

Key Considerations

  • Transfection performance
  • recombinant virus handling
  • host-cell response
  • expression confirmation
  • viral passage
  • inoculum quality.

Deliverables

Expression-verification result and agreed recombinant baculovirus or culture material.

Price

$2,930

Stage 03

Small Scale Expression

Description

Produce the target in infected insect-cell culture and select an appropriate harvest condition.

Key Considerations

  • Infection timing
  • multiplicity where applicable
  • cell density and viability
  • culture duration
  • secretion versus intracellular recovery
  • protein stability.

Deliverables

Small-scale expression result and selected infection or harvest condition.

Price

$370

Stage 04

Basic Protein Purification

Description

Recover the target from cells or culture medium and apply a target-compatible basic affinity-purification route.

Key Considerations

  • Clarification
  • lysis where required
  • tag accessibility
  • aggregates
  • host-cell or virus-related materials
  • buffer compatibility
  • recovery.

Deliverables

Basic purified protein fraction and documented recovery conditions.

Price

Included in the $3,600 package; no separate basic purification fee

Stage 05

Basic Quality Control and Reporting

Description

Assess the purified material by native PAGE, reducing SDS-PAGE and standard project reporting.

Key Considerations

  • Apparent molecular mass
  • oligomeric state
  • concentration
  • product stability
  • host or virus-related considerations
  • intended-use criteria.

Deliverables

Native PAGE, reducing SDS-PAGE and standard COA or study report.

Price

$300 subtotal: Native PAGE $75; reducing SDS-PAGE $75; report $150

Stage 06

Optional Characterization and Process Add Ons

Description

Add protein polishing, endotoxin-control, bioactivity or target-specific impurity work after technical review.

Key Considerations

  • Protein recovery after added processing
  • assay controls
  • virus-related analytical scope
  • method suitability
  • numerical acceptance criteria.

Deliverables

Optional Endotoxin Removal, quotation upon request, target <0.1 EU/µg; Bioactivity Measurement, quoted by assay scope; SEC polishing, buffer exchange or tag cleavage when appropriate.

Price

Quoted separately; <0.1 EU/µg is a target and is not guaranteed

TARGET-SPECIFIC RISK REVIEW

Baculovirus Insect Cell Expression Optimization

Baculovirus Insect Cell expression optimization strategy
Optimization choices depend on construct behavior, host compatibility, protein recovery and the intended research application.

RESEARCH APPLICATIONS

Designed for Diverse Recombinant Protein Programs

  • Viral antigens
  • Multidomain proteins
  • Enzyme research
  • Binding assays
  • Structural biology
  • Drug discovery reagents
Research applications for Baculovirus Insect Cell protein expression

DEFINED BASIC QC

Quality Control and Project Reporting

Basic QC includes native PAGE, reducing SDS-PAGE and a standard COA or study report. Additional analytical work is selected according to the molecule and intended use.

Quality control for Baculovirus Insect Cell recombinant protein

PROJECT PLANNING

Frequently Asked Questions

Which proteins are suitable for baculovirus insect cell expression?

Selected viral antigens, multidomain proteins, enzymes and other complex recombinant targets can be candidates. Required folding, glycosylation, oligomeric state and biological activity determine whether the system is appropriate.

What is included in the standard baculovirus package?

The $3,600 package includes Sf9 transfection and expression verification, small-scale expression, basic protein purification, native PAGE, reducing SDS-PAGE and a standard COA or study report. Gene synthesis and Stage 06 options are separate.

Can I provide my own baculovirus transfer construct?

A customer-supplied construct can be assessed when the vector map, insert sequence, tag arrangement, transfer system, resistance or selection information and available expression history are provided. Verification or adaptation work is agreed before production.

What happens if infection performance or expression is low?

The project can be reviewed for construct behavior, recombinant virus preparation, viral passage, cell condition, infection timing, multiplicity and harvest window. Optimization is separately scoped, and yield remains target dependent.

Can you provide low endotoxin or bioactive insect cell protein?

Optional endotoxin removal and bioactivity measurement can be assessed. The <0.1 EU/µg value is a project target rather than a universal guarantee, and assay design, controls and any virus-related analytical requirements are quoted separately.

START WITH A TECHNICAL REVIEW

Discuss Your Baculovirus Insect Cell Protein Expression Project

Share the target sequence, preferred construct, intended application and requested analytical scope. BioCrestSci will assess feasibility and define a project-specific plan.

Request a Quote
Shopping Cart
Scroll to Top